Showing results (1-10 of 160) with videos related to
Sort By:
Pageof 16
Antibiotics (Basel, Switzerland)|March 27, 2026
Proactive Therapeutic Drug Monitoring of Dalbavancin in the Long-Term Treatment of Chronic Infections: A Narrative ReviewDario Cattaneo, Jessica CusatoClinical Pharmacokinetics|September 20, 2016
Genetic Polymorphisms Affecting the Pharmacokinetics of Antiretroviral DrugsAndrea Calcagno, Jessica Cusato, Antonio D'Avolio, et al.Therapeutic Drug Monitoring|September 3, 2025
Pharmacogenetics of First-Line Antitubercular Drugs: An UpdateAlessandra Manca, Andrea Calcagno, Antonio D'Avolio, et al.Journal of Pharmaceutical and Biomedical Analysis|January 5, 2019
LC-MS application for therapeutic drug monitoring in alternative matricesValeria Avataneo, Antonio D'Avolio, Jessica Cusato, et al.Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|June 6, 2017
Role of IL28B genotype in the liver stiffness increase in untreated patients with chronic hepatitis CLucio Boglione, Jessica Cusato, Giuseppe Cariti, et al.Antiviral Research|February 10, 2015
Treatment optimization of naïve HCV-1 patients using IL28B, RVR and fibrosis stageLucio Boglione, Jessica Cusato, Giuseppe Cariti, et al.European Journal of Public Health|March 25, 2017
Reasons to wait or to treat naive patients affected by chronic hepatitis C with low fibrosis stage and genotypes 2 or 3Lucio Boglione, Jessica Cusato, Giuseppe Cariti, et al.Antiviral Research|November 7, 2016
Role of HBsAg decline in patients with chronic hepatitis B HBeAg-negative and E genotype treated with pegylated-interferonLucio Boglione, Jessica Cusato, Giuseppe Cariti, et al.Pharmacogenomics|December 6, 2017
Precision medicine for HIV: where are we?Jessica Cusato, Sarah Allegra, Amedeo De Nicolò, et al.The Journal of Infection|March 18, 2014
The E genotype of hepatitis B: clinical and virological characteristics, and response to interferonLucio Boglione, Jessica Cusato, Giuseppe Cariti, et al.Pageof 16